ArticleChemistry & biodiversity2026
Exploring Bioactivities, Cytotoxicity, and Anti-Acne Potential of Malaysian Colored Rice (Oryza sativa L. Cv. MRQ 98).
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colored rice has been reported to contain bioactive compounds. This study investigated the phytochemical composition, antioxidant, antibacterial, anti-inflammatory, and cytotoxic properties of Oryza sativa L. Cv. MRQ 98 methanolic (M) and acetone (A) extracts, cultivated exclusively in Skuduk-Chupak, Sarawak, Malaysia. HPLC analysis identified several phenolic acids in both free and bound fraction forms. The DPPH assay showed strong antioxidant activities, with maximal scavenging observed at 10 mg/mL. Anti-inflammatory activity showed more than 50% protection with extract concentrations lower than 2.5 mg/mL. In contrast, antibacterial activity against Cutibacterium acnes, Staphylococcus aureus, and Staphylococcus epidermidis was weak, with IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.